Newsroom | 18833 results

Sorted by: Latest

Managed Care
-

Scholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of patients with rare, severe, and debilitating neuromuscular diseases by applying its world-leading platform in myostatin biology, today announced that the FDA review of the apitegromab Biologics License Application (BLA) for the treatment of children and adults with spinal muscular atrophy (SMA) is progressing with the Company’s second fill-finish facility. The B...
-

AdaptHealth Corp. to Participate in Upcoming Investor Conferences

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the following upcoming investor conferences: The Canaccord Genuity 46th Annual Growth Conference, being held in Boston, on Tuesday, August 11, 2026, including a fireside chat from 9:00 – 9:25 a.m. E...
-

NHC Announces Common Dividend

MURFREESBORO, Tenn.--(BUSINESS WIRE)--National HealthCare Corporation (NYSE American: NHC), the nation’s oldest publicly traded long-term health care company, announced today that it will pay a quarterly dividend of 67 cents per common share to shareholders of record on September 30, 2026 and payable on October 30, 2026. Forward-Looking Statements Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statem...
-

CareTrust REIT Announces Second Quarter 2026 Operating Results; Increases 2026 Guidance

DANA POINT, Calif.--(BUSINESS WIRE)--CareTrust REIT Announces Second Quarter 2026 Operating Results; Increases 2026 Guidance...
-

Phreesia Sets Release Date for Fiscal Second Quarter 2027 Results

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia will release its fiscal second quarter 2027 financial results after the close of market trading on Wednesday, Sept. 2, 2026....
-

Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

DUBLIN--(BUSINESS WIRE)--Prothena reported financial results for the second quarter and first six months of 2026 and provided business highlights....
-

GeneDx to Participate in Upcoming Investor Conferences

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) announced that company management will participate in the Canaccord Genuity and Wells Fargo investor conferences....
-

Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the second quarter ended June 30, 2026. The Company also raised its full-year guidance. Second Quarter Financial Results Revenue of $351.8 million, up 2% year-over-year. Residents served ended the quarter at approximately 210,000, up 8% year-over-year. Net Income of $22.1 million, inclusive of an $8.5 m...
-

Medbridge and Patient360 Partner to Help Practices Protect Medicare Reimbursement

SEATTLE--(BUSINESS WIRE)--Medbridge, the leading digital health platform for clinician education, home exercise programs, patient-reported outcomes, and remote therapeutic monitoring (RTM), today announced a strategic partnership with Patient360, a Centers for Medicare & Medicaid Services (CMS) approved Qualified Clinical Data Registry (QCDR), to deliver Merit-based Incentive Payment System (MIPS) reporting directly from the patient-reported outcomes captured in the Medbridge platform. Prac...
-

Leap Expands Manufacturer & Specialty Network Partnerships with Appointment of Industry Executive Christine Hummel

NEW YORK--(BUSINESS WIRE)--Leap, the healthcare company making specialty medicine more affordable and easier to access, today announced the appointment of Christine Hummel as Senior Vice President of Manufacturer and Specialty Network Partnerships. In this role, she will lead Leap's strategy and partnerships across pharmaceutical manufacturers and specialty care networks, helping expand access to specialty therapies through more transparent and efficient models of care. The appointment reflects...